CEO SUNDAY: Army veteran turned health tech boss calls support for those who served a 'sacred obligation'
Philips North America CEO Jeff DiLullo reflected on finding purpose after military service and why supporting veterans remains a "sacred obligation."
When diesel prices fall, Amazon stock will climb: Aquinas Wealth Advisors CEO
Aquinas Wealth Advisors CEO Chris McMahon discusses anticipated Amazon earnings and shares his top stock picks, including UnitedHealth Group and GE Vernova, on ‘The Claman Countdown.’
Camino Partners invests $62 million in Intake Breathing's magnetic nasal dilator technology
Camino Partners founder Daniel Lubetzky and Intake Breathing co-founder Alex Hauck discuss a $62 million investment in the company's patented magnetic nasal dilator system designed to improve airflow and sleep quality on ‘The Claman Countdown.’
Economist says Obama 'fundamentally broke' US healthcare system, reveals simple fix for Republicans
EJ Antoni says Barack Obama's Affordable Care Act broke the healthcare system, arguing price transparency is key to lowering premiums and costs.
Moderna chairman: Premature release of data was an unfortunate aberration
Moderna co-founder and board chairman Noubar Afeyan discusses the biotech company's melanoma vaccine trial results and efforts to secure FDA approval on 'The Claman Countdown.'
Trump announces $275M nursing-home nurse initiative at Florida midterm rally
President Trump announced a $275 million initiative at a Fort Myers, Florida rally on Friday to recruit and retain more than 4,000 nursing-home nurses nationwide.
Rogue AI bots reportedly discovered in customer accounts at major banks
Forbes Media chairman and editor-in-chief Steve Forbes discusses reports of rogue AI bots being discovered in customer accounts at major banks on 'The Evening Edit.'
Medical company bets on AI-powered drug breakthrough that could extend lifespan to 150
Insilico Medicine founder and CEO Dr. Alex Zhavoronkov details how his company is developing medicine targeting age and disease on ‘Claman’s Power Players.’
AstraZeneca, Insitro strike AI drug discovery deal
Baird investment strategist Ross Mayfield discusses the impact of artificial intelligence on the healthcare industry on ‘The Claman Countdown.’
Walmart to offer free GLP-1 drugs, more than 250 medications as it expands employee health benefits
Walmart is expanding employee health benefits with free GLP-1 medications for Type 2 diabetes, no-cost prescriptions, specialist care and neonatal intensive care leave.
We take patient privacy very seriously, have safeguards in place: Zocdoc CEO
Zocdoc founder and CEO Oliver Kharraz discusses the company’s Care Access Network and partnerships with Amazon, Gemini, Yelp and Blue Shield of California to integrate Zocdoc’s scheduling tools on ‘The Claman Countdown.’
Tempus CEO Eric Lefkofsky on using AI to revolutionize cancer treatment
Tempus founder and CEO Eric Lefkofsky joins 'The Claman Countdown' to discuss how artificial intelligence is transforming precision medicine.
We are generating necessary data to determine what treatments patients need: Tempus CEO
Tempus CEO Eric Lefkofsky discusses the company's artificial intelligence-driven precision medicine partnership with Merck on ‘The Claman Countdown.’
Employers pull back on weight-loss drug coverage
Motley Fool Asset Management chief investment strategist Bill Mann analyzes Eli Lilly's long-term growth potential amid shifts in employer coverage for weight-loss drugs on ‘The Claman Countdown.’
Moderna stock jumps amid announcement of melanoma vaccine treatment
Siebert Financial CIO Mark Malek analyzes the biotech sector bounce, Moderna's growth outlook and Nvidia's upcoming earnings report on ‘Making Money.’
Costco plots major expansion into senior healthcare with Medicare partnership
In a first-of-its-kind venture, Costco is partnering with SCAN Health Plan on senior-focused insurance products that could include pharmacy, vision and hearing benefits.
Novo Nordisk CEO sees ‘long runway’ for weight-loss drugs as obesity grips America
Novo Nordisk CEO argues weight loss drugs could slash healthcare costs and boost productivity as GLP-1 adoption remains in its early innings.
GoodRx CEO details partnership with TrumpRx
GoodRx President and CEO Wendy Barnes discusses the company's partnership with TrumpRx on 'The Claman Countdown.'
GoodRx CEO details TrumpRx partnership to lower prescription drug costs
GoodRx CEO Wendy Barnes discusses the company's partnership with TrumpRx and efforts to lower prescription drug costs on ‘The Claman Countdown.’
Strategist points to healthcare if investors want to diversify portfolio outside of AI
Empower chief investment strategist Marta Norton joins 'The Claman Countdown' to discuss the resilient consumer and how to diversify your portfolio.